NewAmsterdam Pharma N.V. (NAMS)
17.52
0.25 (1.45%)
At close: Apr 24, 2025, 3:59 PM
17.22
-1.71%
Pre-market: Apr 25, 2025, 08:12 AM EDT
NewAmsterdam Pharma Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
42
Upside
139.73
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Needham | Buy | Reiterates | 42 42 | 139.73% | Apr 8, 2025 | |
| Scotiabank | Buy | Maintains | 47 52 | 196.80% | Feb 27, 2025 | |
| Needham | Buy | Maintains | 46 42 | 139.73% | Feb 27, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.